NREP
NEW REPRESENTATIVE AT IB RECEIVED
07/30/2026
Back to search
Official data from USPTO
T
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: United States
Quick snapshot
ST13
US500000079386129Class
5, 9, 10, 42, 44
Filing
79386129
Registration
7772609
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
41
Latest update
07/30/2026
Trademark type
Combined
Nice classes
5, 9, 10, 42, 44
Filing date
11/14/2023
Registration date
04/29/2025
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
04/29/2025
Last transaction
07/30/2026
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Drawing code
3
Owner type
99
Owner location
AU
Examiner
FEDERICO, EVAN G
Law office
O40
Current location
FILE REPOSITORY (FRANCONIA)
Mark description
The mark consists of four blue triangles facing inward to form a circle containing a stylized lowercase letter "T". There is a blue circle in the center of the four triangles. The color white serves as background areas and is not claimed as a feature of the mark.
Holders and representatives
Holders
Telix Pharmaceuticals Limited
Representatives
Andrew S. Ehard
Technical classification
Nice Classes
Class 5Class 9Class 10Class 42Class 44
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Pharmaceutical preparations for the treatment of cancer; Chemical preparations for pharmaceutical purposesdiagnostic radiopharmaceutical preparations; Contrast media for use with medical equipment; Diagnostic agents for medical use in in vivo scanning; Compositions for medical usechemical products for pharmaceutical usechemical preparations for the preventiondiagnosistreatment or improvement of conditions and disorderscancer; Chemicals for pharmaceutical use for the treatmentpreventiondiagnosis of cancer
Class 9
Downloadable computer operating software; Downloadable computer application software for mobile phonesportable media playershandheld computerssoftware for the treatmentpreventiondiagnosis of cancer; Software as a Medical Device (SaMD)downloadablefor the treatmentpreventiondiagnosis of cancer; Downloadable computer programs for medical purposesfor the treatmentpreventiondiagnosis of cancer; Downloadable computer programs for the treatmentpreventiondiagnosis of cancer
Class 10
Apparatus for administering pharmaceuticals for the treatmentpreventiondiagnosis of cancermedical apparatus for introducing pharmaceutical preparations into the human body for the treatmentpreventiondiagnosis of cancer; apparatus for medical purposes for the treatmentpreventiondiagnosis of cancerinjection needlesinjection syringesradiological apparatus for the treatmentpreventiondiagnosis of cancer; medical apparatus for the treatment of cancer; applicators for pharmaceutical preparationsapplicators for pharmaceutical preparations sold without medication; pharmaceutical instrumentsradiological apparatus for medical purposesmedical apparatus for the treatment of cancer and diseases associated with cellular proliferationimaging apparatus for medical use for diagnosing medical conditions; medical apparatus for use in laparoscopy; Medical apparatus for detecting cancer; Surgical instruments and apparatus; detecting instruments for medical use for detecting cancer; Medical instruments for use in the treatmentpreventiondiagnosis of cancer; Test equipment for medical usemedical diagnostic instrument for cancer; diagnostic imaging apparatus for medical use; medical imaging apparatus; Probes for medical purposes; surgical instruments in the nature of surgical probes; surgical robots; nanorobots for medical purposes for surgical use
Class 42
Software as a service (SAAS) services featuring software for the treatmentpreventiondiagnosis of cancer; computer software design; computer software development; computer software programming services for others in the field of medicine; development of software for the treatmentpreventiondiagnosis of cancer; Software as a service (SAAS) serviceshosting software for use by others for the treatmentpreventiondiagnosis of cancer; installation of computer software; software creation in the nature of computer software design; software engineering services; Design and writing of computer software; online provision of web-based applicationsproviding temporary use of on-line non-downloadable applications for the treatmentpreventiondiagnosis of cancer; online provision of web-based softwareproviding temporary use of online non-downloadable software for the treatmentpreventiondiagnosis of cancer; Consultancy in the field of artificial intelligence technology; research in the field of artificial intelligence technology
Class 44
Medical analysis services for the diagnosis and treatment of persons with cancer; medical analysis services relating to the treatment of persons; medical diagnostic services; medical health assessment services; services for the preparation of medical reportsproviding medical information to patientsin the form of reports in the field of cancer; advisory services relating to medical services; consultancy and advisory services in relation to medical services; provision of medical information; Consulting services in the field of healthcare; health screening services in the field of cancer; providing information relating to health care services; preparation of reports relating to health care matters for medical purposes
Publications
History of USPTO decisions and trademark events.
41 publications found
NREP
NEW REPRESENTATIVE AT IB RECEIVED
01/22/2026
NREP
NEW REPRESENTATIVE AT IB RECEIVED
01/01/2026
FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
12/05/2025
FICS
FINAL DISPOSITION NOTICE SENT TO IB
11/15/2025
FIMP
FINAL DISPOSITION PROCESSED
11/14/2025
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
07/29/2025
OPNX
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
06/13/2025
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
05/27/2025
OPNR
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
05/27/2025
NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
04/29/2025
R.PR
REGISTERED-PRINCIPAL REGISTER
04/29/2025
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
03/11/2025
PUBO
PUBLISHED FOR OPPOSITION
03/11/2025
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
03/05/2025
ALIE
ASSIGNED TO LIE
02/18/2025
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
02/13/2025
XAEC
EXAMINER'S AMENDMENT ENTERED
02/13/2025
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
02/13/2025
GNEA
EXAMINERS AMENDMENT E-MAILED
02/13/2025
CNEA
EXAMINERS AMENDMENT -WRITTEN
02/13/2025
ZZZX
PREVIOUS ALLOWANCE COUNT WITHDRAWN
02/13/2025
PBCR
WITHDRAWN FROM PUB - OG REVIEW QUERY
02/11/2025
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
01/27/2025
XAEC
EXAMINER'S AMENDMENT ENTERED
01/27/2025
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
01/27/2025
GNEA
EXAMINERS AMENDMENT E-MAILED
01/27/2025
CNEA
EXAMINERS AMENDMENT -WRITTEN
01/27/2025
DOCK
ASSIGNED TO EXAMINER
01/26/2025
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
10/02/2024
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
10/02/2024
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
10/02/2024
RFNT
REFUSAL PROCESSED BY IB
05/01/2024
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
04/06/2024
RFRR
REFUSAL PROCESSED BY MPU
04/06/2024
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
03/19/2024
CNRT
NON-FINAL ACTION WRITTEN
03/18/2024
DOCK
ASSIGNED TO EXAMINER
03/14/2024
MAFR
APPLICATION FILING RECEIPT MAILED
01/02/2024
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
12/29/2023
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
12/28/2023
Continuous trademark protection
Get notified about every new filing that threatens T or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.